{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:25:46Z","timestamp":1791170746397,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":47,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642247156","type":"print"},{"value":"9783642247163","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-24716-3_15","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T12:20:09Z","timestamp":1326716409000},"page":"339-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reuptake Inhibitors of Dopamine, Noradrenaline, and Serotonin"],"prefix":"10.1007","author":[{"given":"Ulrich","family":"Kintscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,10]]},"reference":[{"key":"15_CR1_15","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(08)61525-1","volume":"372","author":"A Astrup","year":"2008","unstructured":"Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM (2008) Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet 372:1906\u20131913","journal-title":"Lancet"},{"key":"15_CR2_15","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/npp.2010.16","volume":"35","author":"AM Axel","year":"2010","unstructured":"Axel AM, Mikkelsen JD, Hansen HH (2010) Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology 35:1464\u20131476","journal-title":"Neuropsychopharmacology"},{"key":"15_CR3_15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/DDDT.S11859","volume":"5","author":"NT Bello","year":"2011","unstructured":"Bello NT, Liang NC (2011) The use of serotonergic drugs to treat obesity \u2013 is there any hope? Drug Des Devel Ther 5:95\u2013109","journal-title":"Drug Des Devel Ther"},{"key":"15_CR4_15","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","volume":"106","author":"AL Birkenfeld","year":"2002","unstructured":"Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, Jordan J (2002) Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation 106:2459\u20132465","journal-title":"Circulation"},{"key":"15_CR5_15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1210\/er.20.6.805","volume":"20","author":"GA Bray","year":"1999","unstructured":"Bray GA, Greenway FL (1999) Current and potential drugs for treatment of obesity. Endocr Rev 20:805\u2013875","journal-title":"Endocr Rev"},{"key":"15_CR6_15","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1074\/jbc.M307788200","volume":"279","author":"R Burcelin","year":"2004","unstructured":"Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M, Seydoux J, Cotecchia S, Thorens B (2004) Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem 279:1108\u20131115","journal-title":"J Biol Chem"},{"key":"15_CR7_15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology 27:699\u2013711","journal-title":"Neuropsychopharmacology"},{"key":"15_CR8_15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.lfs.2007.08.004","volume":"81","author":"PS Clifford","year":"2007","unstructured":"Clifford PS, Davis KW, Elliott AE, Wellman PJ (2007) Effects of ICV administration of the alpha1A-adrenoceptor antagonist 5-methylurapidil on concurrent measures of eating and locomotion after cocaine in the rat. Life Sci 81:1059\u20131065","journal-title":"Life Sci"},{"key":"15_CR9_15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581\u2013588","journal-title":"N Engl J Med"},{"key":"15_CR10_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.99.1.156","volume":"99","author":"AP Fishman","year":"1999","unstructured":"Fishman AP (1999) Aminorex to fen\/phen: an epidemic foretold. Circulation 99:156\u2013161","journal-title":"Circulation"},{"key":"15_CR11_15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-2999(00)00216-8","volume":"397","author":"SD Glick","year":"2000","unstructured":"Glick SD, Haskew RE, Maisonneuve IM, Carlson JN, Jerussi TP (2000) Enantioselective behavioral effects of sibutramine metabolites. Eur J Pharmacol 397:93\u2013102","journal-title":"Eur J Pharmacol"},{"key":"15_CR12_15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0014-2999(85)90578-3","volume":"115","author":"CK Goldman","year":"1985","unstructured":"Goldman CK, Marino L, Leibowitz SF (1985) Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular nucleus injection of norepinephrine and clonidine. Eur J Pharmacol 115:11\u201319","journal-title":"Eur J Pharmacol"},{"key":"15_CR13_15","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1210\/jc.2009-1350","volume":"94","author":"FL Greenway","year":"2009","unstructured":"Greenway FL, Dunayevich E, Tollefson G, Erickson J, Guttadauria M, Fujioka K, Cowley MA (2009a) Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. J Clin Endocrinol Metab 94:4898\u20134906","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR14_15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","volume":"376","author":"FL Greenway","year":"2010","unstructured":"Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E (2010) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 376:595\u2013605","journal-title":"Lancet"},{"key":"15_CR15_15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/oby.2008.461","volume":"17","author":"FL Greenway","year":"2009","unstructured":"Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K, Gadde KM, Gupta AK, O\u2019Neil P, Schumacher D, Smith D, Dunayevich E, Tollefson GD, Weber E, Cowley MA (2009b) Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring) 17:30\u201339","journal-title":"Obesity (Silver Spring)"},{"key":"15_CR16_15","first-page":"437","volume":"14","author":"E Greiser","year":"1973","unstructured":"Greiser E (1973) Epidemiologic studies on the relation between use of appetite depressants and primary vascular pulmonary hypertension. Internist (Berl) 14:437\u2013442","journal-title":"Internist (Berl)"},{"key":"15_CR17_15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/j.1552-4604.1967.tb00067.x","volume":"7","author":"AJ Hadler","year":"1967","unstructured":"Hadler AJ (1967) Studies of aminorex, a new anorexigenic agent. J Clin Pharmacol J New Drugs 7:296\u2013302","journal-title":"J Clin Pharmacol J New Drugs"},{"key":"15_CR18_15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pharmthera.2010.12.002","volume":"129","author":"B Haenisch","year":"2011","unstructured":"Haenisch B, Bonisch H (2011) Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther 129:352\u2013368","journal-title":"Pharmacol Ther"},{"key":"15_CR19_15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"DL Hansen","year":"1998","unstructured":"Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A (1998) Thermogenic effects of sibutramine in humans. Am J Clin Nutr 68:1180\u20131186","journal-title":"Am J Clin Nutr"},{"key":"15_CR20_15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejphar.2010.03.026","volume":"636","author":"HH Hansen","year":"2010","unstructured":"Hansen HH, Hansen G, Tang-Christensen M, Larsen PJ, Axel AM, Raben A, Mikkelsen JD (2010) The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. Eur J Pharmacol 636:88\u201395","journal-title":"Eur J Pharmacol"},{"key":"15_CR21_15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-006-0285-2","volume":"326","author":"L Hein","year":"2006","unstructured":"Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541\u2013551","journal-title":"Cell Tissue Res"},{"key":"15_CR22_15","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ (1997) Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613\u20131618","journal-title":"Br J Pharmacol"},{"key":"15_CR23_15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL (2010) Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 363:905\u2013917","journal-title":"N Engl J Med"},{"key":"15_CR24_15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.ijo.0802887","volume":"29","author":"J Jordan","year":"2005","unstructured":"Jordan J, Scholze J, Matiba B, Wirth A, Hauner H, Sharma AM (2005) Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials. Int J Obes (Lond) 29:509\u2013516","journal-title":"Int J Obes (Lond)"},{"key":"15_CR25_15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/07853890.2010.541490","volume":"43","author":"N Katsiki","year":"2011","unstructured":"Katsiki N, Hatzitolios AI, Mikhailidis DP (2011) Naltrexone sustained-release (SR)\u2009+\u2009bupropion SR combination therapy for the treatment of obesity: \u2018A new kid on the block\u2019? Ann Med 43:249\u2013258","journal-title":"Ann Med"},{"key":"15_CR26_15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/226963a0","volume":"226","author":"SF Leibowitz","year":"1970","unstructured":"Leibowitz SF (1970a) Hypothalamic beta-adrenergic \u201csatiety\u201d system antagonizes an alpha-adrenergic \u201chunger\u201d system in the rat. Nature 226:963\u2013964","journal-title":"Nature"},{"key":"15_CR27_15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1073\/pnas.67.2.1063","volume":"67","author":"SF Leibowitz","year":"1970","unstructured":"Leibowitz SF (1970b) Reciprocal hunger-regulating circuits involving alpha- and beta-adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus. Proc Natl Acad Sci USA 67:1063\u20131070","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR28_15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0091-3057(85)90416-2","volume":"23","author":"SF Leibowitz","year":"1985","unstructured":"Leibowitz SF, Brown O, Tretter JR, Kirschgessner A (1985) Norepinephrine, clonidine, and tricyclic antidepressants selectively stimulate carbohydrate ingestion through noradrenergic system of the paraventricular nucleus. Pharmacol Biochem Behav 23:541\u2013550","journal-title":"Pharmacol Biochem Behav"},{"key":"15_CR29_15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/j.1550-8528.1994.tb00061.x","volume":"2","author":"MF Lesses","year":"1994","unstructured":"Lesses MF, Myerson A (1994) Human autonomic pharmacology. XVI. Benzedrine sulfate as an aid in the treatment of obesity. 1938. Obes Res 2:286\u2013292","journal-title":"Obes Res"},{"key":"15_CR30_15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","volume":"142","author":"Z Li","year":"2005","unstructured":"Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC (2005) Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 142:532\u2013546","journal-title":"Ann Intern Med"},{"key":"15_CR31_15","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1523\/JNEUROSCI.18-14-05537.1998","volume":"18","author":"JJ Lucas","year":"1998","unstructured":"Lucas JJ, Yamamoto A, Scearce-Levie K, Saudou F, Hen R (1998) Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci 18:5537\u20135544","journal-title":"J Neurosci"},{"key":"15_CR32_15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","volume":"369","author":"RS Padwal","year":"2007","unstructured":"Padwal RS, Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369:71\u201377","journal-title":"Lancet"},{"key":"15_CR33_15","doi-asserted-by":"crossref","unstructured":"Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P (2009) Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev: CD006219","DOI":"10.1002\/14651858.CD006219.pub2"},{"key":"15_CR34_15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0163-7258(02)00234-6","volume":"95","author":"RB Rothman","year":"2002","unstructured":"Rothman RB, Baumann MH (2002) Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol Ther 95:73\u201388","journal-title":"Pharmacol Ther"},{"key":"15_CR35_15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32\u201341","journal-title":"Synapse"},{"key":"15_CR36_15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1124\/jpet.103.049684","volume":"305","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Clark RD, Partilla JS, Baumann MH (2003) (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J Pharmacol Exp Ther 305:1191\u20131199","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR37_15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","volume":"335","author":"D Rucker","year":"2007","unstructured":"Rucker D, Padwal R, Li SK, Curioni C, Lau DC (2007) Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 335:1194\u20131199","journal-title":"BMJ"},{"key":"15_CR38_15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","volume":"73","author":"R Samanin","year":"1993","unstructured":"Samanin R, Garattini S (1993) Neurochemical mechanism of action of anorectic drugs. Pharmacol Toxicol 73:63\u201368","journal-title":"Pharmacol Toxicol"},{"key":"15_CR39_15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"JJ Schildkraut","year":"1965","unstructured":"Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509\u2013522","journal-title":"Am J Psychiatry"},{"key":"15_CR40_15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406\u2013433","journal-title":"Prog Neurobiol"},{"issue":"Suppl 4","key":"15_CR41_15","doi-asserted-by":"crossref","first-page":"515S","DOI":"10.1002\/j.1550-8528.1995.tb00221.x","volume":"3","author":"P Terry","year":"1995","unstructured":"Terry P, Gilbert DB, Cooper SJ (1995) Dopamine receptor subtype agonists and feeding behavior. Obes Res 3(Suppl 4):515S\u2013523S","journal-title":"Obes Res"},{"key":"15_CR42_15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0006-8993(92)91001-U","volume":"587","author":"S Tsujii","year":"1992","unstructured":"Tsujii S, Bray GA (1992) Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. Brain Res 587:226\u2013232","journal-title":"Brain Res"},{"key":"15_CR43_15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/clpt.2010.57","volume":"87","author":"MA Valentino","year":"2010","unstructured":"Valentino MA, Lin JE, Waldman SA (2010) Central and peripheral molecular targets for antiobesity pharmacotherapy. Clin Pharmacol Ther 87:652\u2013662","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR44_15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s002130050952","volume":"143","author":"SP Vickers","year":"1999","unstructured":"Vickers SP, Clifton PG, Dourish CT, Tecott LH (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl) 143:309\u2013314","journal-title":"Psychopharmacology (Berl)"},{"key":"15_CR45_15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/archinte.1984.00350180055008","volume":"144","author":"M Weintraub","year":"1984","unstructured":"Weintraub M, Hasday JD, Mushlin AI, Lockwood DH (1984) A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med 144:1143\u20131148","journal-title":"Arch Intern Med"},{"key":"15_CR46_15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0024-3205(93)90243-V","volume":"53","author":"PJ Wellman","year":"1993","unstructured":"Wellman PJ, Davies BT, Morien A, McMahon L (1993) Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors. Life Sci 53:669\u2013679","journal-title":"Life Sci"},{"key":"15_CR47_15","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J (2001) Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 286:1331\u20131339","journal-title":"JAMA"}],"container-title":["Handbook of Experimental Pharmacology","Appetite Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-24716-3_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T06:11:47Z","timestamp":1675923107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-24716-3_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"ISBN":["9783642247156","9783642247163"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-24716-3_15","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]},"assertion":[{"value":"10 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}